PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
GOLDEN -- PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova... Read More
Wednesday May 20, 2020
PharmaJet appoints Chris Cappello new CEO
GOLDEN -- PharmaJet today announced the appointment of Chris Cappello to president and CEO. Cappelllo replaces Ron Lowy , who was appointed executive chair of the companys board of directors.... Read More
Wednesday April 29, 2020
PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 vaccine
GOLDEN -- PharmaJet , maker of needle-free injection technology, announced its TropisNeedle-free injection system will be used to deliver a COVID-19 vaccine being developed by Immunomic Therapeutics,... Read More
Wednesday April 15, 2020
PharmaJet appoints pharmaceutical exec Marie Mazur to board of directors
GOLDEN -- PharmaJet , maker of innovative, needle-free injection technology, announced Dr. Marie Mazur has been appointed to its board of directors. Mazur is a global business executive with... Read More
Friday March 27, 2020
PharmaJet receives $9.6M award to support next-gen needle-free devices
GOLDEN -- PharmaJet , maker of innovative, needle-free injection technology, announced it received a $9.6 million contract award from the Joint Science and Technology Office of the U.S. Defense... Read More
Wednesday March 18, 2020
First large-scale vaccination campaign using PharmaJet needle-free injector results announced
GOLDEN -- PharmaJet , maker of innovative, needle-free injection technology, today announced publication of independent survey results from the first large-scale campaign using its needle-free... Read More
Thursday February 6, 2020
PharmaJet: Trial successful for cancer vaccine using needle-free system
GOLDEN -- PharmaJet , maker of needle-free injection technology, announced the Invectys PhaseI clinical trial of its therapeutic cancer vaccine, INVAC-1, using the PharmaJet needle-free injection... Read More
Friday January 10, 2020
.jpg)
PharmaJet needle-free tech to be used by Vaccibody for cancer trial
GOLDEN -- PharmaJet , maker of innovative, needle-free injection technology, announced that Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis... Read More
Thursday April 19, 2018
IN Sponsors
Browse
Entrepreneurial by Nature
